Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
$4.3M
Market Cap • 06/05/20242017
(há 7 anos)
2022
(2 years ago)
NASDAQ
Listagem
Bridgewater
Sede • New JerseyValuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
THARSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.